François Bertucci
Researcher Next ID · RN-032553
Researcher · Biochemistry, Genetics and Molecular Biology
Centre National de la Recherche Scientifique
Paris, France
- Works count
- 1,348
- Citation count
- 34,102
- H-index
- 96
- i10-index
- 420
Research interests
Publications
An integrated tumor, immune and microbiome atlas of colon cancer
Nature Medicine · 2023 · https://doi.org/10.1038/s41591-023-02324-5
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Cell Research · 2022 · https://doi.org/10.1038/s41422-022-00614-0
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial
The Lancet Oncology · 2022 · https://doi.org/10.1016/s1470-2045(22)00380-1
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial
The Lancet Oncology · 2022 · https://doi.org/10.1016/s1470-2045(22)00380-1
Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study
The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30276-1
Surgery in reference centers improves survival of sarcoma patients: a nationwide study
Annals of Oncology · 2019 · https://doi.org/10.1093/annonc/mdz124
Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group
European Journal of Cancer · 2017 · https://doi.org/10.1016/j.ejca.2017.06.017
Improved survival using specialized multidisciplinary board in sarcoma patients
Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx484
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis
OncoImmunology · 2017 · https://doi.org/10.1080/2162402x.2016.1253654
Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France
European Journal of Cancer · 2016 · https://doi.org/10.1016/j.ejca.2016.02.008
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)30507-1
Genomic Characterization of Primary Invasive Lobular Breast Cancer
Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.64.0334
Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial
The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)00075-9
Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets
Clinical Cancer Research · 2013 · https://doi.org/10.1158/1078-0432.ccr-12-2549
CD47–signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction
Proceedings of the National Academy of Sciences · 2011 · https://doi.org/10.1073/pnas.1106550108
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Journal of Clinical Investigation · 2011 · https://doi.org/10.1172/jci45816
Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial
BMC Cancer · 2011 · https://doi.org/10.1186/1471-2407-11-72
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial
The Lancet Oncology · 2010 · https://doi.org/10.1016/s1470-2045(10)70222-9
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome
Blood · 2008 · https://doi.org/10.1182/blood-2008-07-168096
Current projects
No projects listed.